However, it is unclear whether r84 directly inhibits lymphangiogenesis in vivo by preventing VEGF-A from activating VEGFR2 on LECs or indirectly suppresses lymphangiogenesis by affecting other cell types in the tumor microenvironment. The gene discussed is VEGFA; the disease is neoplasm.